|

Heart Disease Clinical Trials in New Hampshire

20 recruiting studies across 4 cities

All Trials in New Hampshire

Phase
Trial Phase Location
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart ValveN/ALebanon
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Lebanon
Cardiac Arrest - Ultrasound Detection of Occult Perfusion—Lebanon
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) SystemN/ALebanon
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/ALebanon
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—Lebanon
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Lebanon
PARTNER 3 Trial - Aortic Valve-in-ValveN/ALebanon
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRN/ALebanon
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—Lebanon
Product Surveillance Registry—Lebanon
Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease—Lebanon
Quality of Pediatric Resuscitation in a Multicenter Collaborative—Lebanon
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—Lebanon
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementN/ALebanon
CCM OPEN HF Registry—Londonderry
Assessment of CCM in HF With Higher Ejection FractionN/AManchester
The HALT Biomarker StudyPhase 1Manchester
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Portsmouth
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Portsmouth

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.